Australia markets closed

Cisen Pharmaceutical Co., Ltd. (603367.SS)

Shanghai - Shanghai Delayed price. Currency in CNY
Add to watchlist
17.86-0.84 (-4.49%)
At close: 3:00PM CST
Currency in CNY

Valuation measures

Market cap (intra-day) 58.1B
Enterprise value 35.77B
Trailing P/E 16.40
Forward P/E 1N/A
PEG ratio (5-yr expected) 1N/A
Price/sales (ttm)2.05
Price/book (mrq)1.74
Enterprise value/revenue 31.46
Enterprise value/EBITDA 69.30

Trading information

Stock price history

Beta (5Y monthly) 0.25
52-week change 339.34%
S&P500 52-week change 314.75%
52-week high 320.65
52-week low 313.21
50-day moving average 316.87
200-day moving average 316.78

Share statistics

Avg vol (3-month) 35.37M
Avg vol (10-day) 311.17M
Shares outstanding 5453.35M
Float 147.6M
% held by insiders 172.89%
% held by institutions 10.38%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.27
Forward annual dividend yield 41.49%
Trailing annual dividend rate 30.27
Trailing annual dividend yield 31.43%
5-year average dividend yield 4N/A
Payout ratio 424.04%
Dividend date 3N/A
Ex-dividend date 415 Jul 2020
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2019
Most-recent quarter (mrq)31 Mar 2020

Profitability

Profit margin 12.50%
Operating margin (ttm)11.72%

Management effectiveness

Return on assets (ttm)5.15%
Return on equity (ttm)11.06%

Income statement

Revenue (ttm)3.94B
Revenue per share (ttm)8.71
Quarterly revenue growth (yoy)-17.10%
Gross profit (ttm)2.32B
EBITDA 620.74M
Net income avi to common (ttm)492.93M
Diluted EPS (ttm)1.09
Quarterly earnings growth (yoy)-17.00%

Balance sheet

Total cash (mrq)2.57B
Total cash per share (mrq)5.71
Total debt (mrq)300M
Total debt/equity (mrq)6.48
Current ratio (mrq)3.52
Book value per share (mrq)10.28

Cash flow statement

Operating cash flow (ttm)206.31M
Levered free cash flow (ttm)2B